Targeting FGFR in bladder cancer: ready for clinical practice?

作者
Stijn De Keukeleire,Daan Joost De Maeseneer,Celine Jacobs,Sylvie Rottey
出处
期刊:Acta Clinica Belgica [Taylor & Francis]
卷期号:75 (1): 49-56 被引量:8
标识
DOI:10.1080/17843286.2019.1685738
摘要

Objective: To give a brief literature overview of current knowledge regarding FGFR inhibition in bladder cancer.Background: The deeper molecular understanding of bladder urothelial carcinoma (UC) has reshaped the diagnostic and therapeutic landscape of this malignancy. Rapid technological development, including the frequent use of next-generation sequencing (NGS) in clinical practice, has boosted identification and development of potential biomarkers and targeted therapies. Genetic aberrations in the fibroblast growth factor receptor (FGFR)-pathway may drive tumorigenesis and are considered as attractive drug targets in advanced and/or metastatic UC. Several clinical trials have been performed or are ongoing to assess the safety and efficacy of (non-)selective FGFR inhibitors in patients with advanced or metatastic UC.Results: While non-selective FGFR inhibitors have shown limited clinical response with unacceptable toxicity, selective ‘pan’-FGFR inhibitors had favourable response rates with manageable toxicity. To predict response, patients were screened for FGFR aberrations using NGS after DNA/RNA extraction of UC tissue specimen or collection of ctDNA or cfDNA.Conclusion: Early clinical trials have shown promising results for targeting FGFR in advanced or metastatic UC, though these findings need to be validated in phase III trials. It seems that FGFR aberrations can be detected in ctDNA and cfDNA as efficiently as in tumour tissue, showing their potential as predictive, non-invasive liquid biomarkers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wwwwzzzz发布了新的文献求助10
刚刚
彭于彦祖的应助被DD采纳,获得30
刚刚
刚刚
xixi发布了新的文献求助10
1秒前
可爱的函函的应助被直率青筠采纳,获得10
1秒前
1秒前
2秒前
2秒前
3秒前
3秒前
风汐5423发布了新的文献求助10
3秒前
3秒前
3秒前
3秒前
3秒前
Cheng发布了新的文献求助10
4秒前
4秒前
ldngis完成签到,获得积分10
4秒前
JUAN完成签到,获得积分10
4秒前
赘婿的应助被怪奇物语采纳,获得10
4秒前
小何的应助被ale采纳,获得10
4秒前
yu发布了新的文献求助30
5秒前
5秒前
阳光荠发布了新的文献求助10
5秒前
ZXDDDD发布了新的文献求助10
6秒前
Lunyx发布了新的文献求助30
6秒前
starry发布了新的文献求助10
7秒前
Lucas的应助被冰淇淋灭火器采纳,获得10
7秒前
吃饭饭发布了新的文献求助10
7秒前
Kare完成签到,获得积分10
8秒前
8秒前
1111发布了新的文献求助10
8秒前
酷酷的丝袜完成签到 ,获得积分20
9秒前
班小班完成签到,获得积分10
9秒前
wan完成签到 ,获得积分10
9秒前
9秒前
9秒前
9秒前
小象发布了新的文献求助10
10秒前
高沅发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156